Joe Bolen
Directeur/Membre du Conseil chez Aelin Therapeutics NV
Profil
Joseph B.
Bolen is currently an Independent Director at Aelin Therapeutics NV and an Entrepreneur Partner at MPM BioImpact, Inc. Previously, he held positions such as Director-Cellular Signaling Department at Bristol-Myers Squibb Pharma Research Labs LLC, Founding Director at DNAX Research, Inc., Chief Scientific Officer & Head-Oncology Research at Millennium Pharmaceuticals, Inc., and Vice President & Head-Oncologic Diseases at Hoechst Marion Roussel, Inc. He has also served as a Scientist at the National Institutes of Health, a Professor & Member-Graduate Faculty at Princeton University, and an Advisor at Robert Wood Johnson Medical School.
Additionally, he was the President & Chief Scientific Officer at ModernaTX, Inc. and Moderna, Inc. He has been the Chief Scientific Officer at PureTech Health Plc from 2016 to 2023.
Dr. Bolen received his undergraduate degree from the University of Nebraska and his doctorate from Kansas State University.
Postes actifs de Joe Bolen
| Sociétés | Poste | Début |
|---|---|---|
Aelin Therapeutics NV
 Aelin Therapeutics NV Pharmaceuticals: MajorHealth Technology Aelin Therapeutics NV develops drugs for antibiotics and first-in-class therapeutics. The company is based in Leuven, Belgium. The Belgian company was founded in 2017. The CEO is Els Beirnaert. | Directeur/Membre du Conseil | - |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Private Equity Investor | 01/05/2023 |
Anciens postes connus de Joe Bolen
| Sociétés | Poste | Fin |
|---|---|---|
| PURETECH HEALTH PLC | Directeur Technique/Scientifique/R&D | 01/02/2023 |
| MODERNA, INC. | President | - |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Directeur Technique/Scientifique/R&D | - |
| DNAX Research, Inc. | Corporate Officer/Principal | - |
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | President | - |
Formation de Joe Bolen
| University of Nebraska | Undergraduate Degree |
| Kansas State University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PURETECH HEALTH PLC | Health Technology |
| MODERNA, INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Bristol-Myers Squibb Pharma Research Labs LLC
 Bristol-Myers Squibb Pharma Research Labs LLC Miscellaneous Commercial ServicesCommercial Services Bristol-Myers Squibb Pharma Research Labs LLC researches and develops drugs and related pharmaceutical products. The company is headquartered in San Diego, CA | Commercial Services |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Health Technology |
| Hoechst Marion Roussel, Inc. | |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
| DNAX Research, Inc. | |
Aelin Therapeutics NV
Aelin Therapeutics NV Pharmaceuticals: MajorHealth Technology Aelin Therapeutics NV develops drugs for antibiotics and first-in-class therapeutics. The company is based in Leuven, Belgium. The Belgian company was founded in 2017. The CEO is Els Beirnaert. | Health Technology |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Finance |
